Older adults with insulin resistance have higher levels of the IGF-1 receptor in their muscles at rest, which may be the body’s way of trying to maintain muscle-building signals when insulin signaling is impaired.
Claim Context
In older adults with insulin resistance, skeletal muscle insulin-like growth factor 1 receptor (IGFRβ) is elevated at baseline compared to young adults, suggesting a compensatory upregulation of alternative anabolic signaling pathways in the context of reduced insulin sensitivity.
“Basal skeletal muscle IGFRβ (Fig. 4F) was increased in insulin-resistant older versus young adults (P = 0.022).”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether elevated basal IGFRβ is a consistent feature across older adults with insulin resistance and whether it correlates with preserved anabolic signaling.
A systematic review and meta-analysis of 12+ studies measuring basal muscle IGFRβ in adults aged 60+ with insulin resistance (HOMA-IR > 3.0) compared to age-matched insulin-sensitive controls, with standardized biopsy and Western blot methods.
Whether blocking IGFRβ reduces anabolic signaling in older adults with insulin resistance despite high insulin.
A double-blind RCT of 60 older adults (65–75 years) with insulin resistance, randomized to receive an IGFRβ inhibitor or placebo for 8 weeks, with all participants receiving 25 g whey protein + resistance exercise; primary outcomes: p-Akt308, p-4E-BP1, and MPS via tracer kinetics.
Whether higher basal IGFRβ predicts slower muscle loss over time in older adults with insulin resistance.
A 5-year prospective cohort study of 200 older adults (65+ years) with insulin resistance, measuring baseline muscle IGFRβ via biopsy and tracking annual changes in lean mass (DXA) and MPS (tracer kinetics), adjusting for protein intake and activity.
Whether older adults with preserved vs. impaired MPS after protein have different basal IGFRβ levels.
A case-control study comparing 40 older adults (70+ years) with preserved MPS (>15% increase after protein) to 40 with impaired MPS (<5% increase), matched for HOMA-IR and BMI, measuring basal muscle IGFRβ via biopsy.
Whether basal IGFRβ levels correlate with insulin sensitivity in older adults.
A cross-sectional analysis of 180 older adults (65–75 years) measuring basal muscle IGFRβ and HOMA-IR, adjusting for age, sex, BMI, and physical activity.